Skip to content
Screener

Medpace Holdings, Inc. MEDP Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$28.39M+5.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
NeoGenomics logo
NeoGenomicsNEO
Simulations Plus logo
Simulations PlusSLP
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.33B+35.1%
Enterprise value$15.97B+31.0%
P/E33.2×+4.3×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
Line itemAs of / June 30,2026As of / December 31,2025
Employee compensation and benefits$79,428$80,139
Project related reimbursable expenses356,929316,013
Other14,71912,230
Total accrued expenses$451,076$408,382

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s accrued manufacturing costs?
Medpace Holdings, Inc. (MEDP) reported accrued manufacturing costs of $79.43M in Q2 2026.
How has Medpace Holdings, Inc.'s accrued manufacturing costs changed year-over-year?
Medpace Holdings, Inc.'s accrued manufacturing costs increased by 16.4% year-over-year, from $68.24M to $79.43M.
What is the long-term trend for Medpace Holdings, Inc.'s accrued manufacturing costs?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s accrued manufacturing costs has grown at a 8.5% compound annual growth rate (CAGR), from $57.85M to $80.14M.

Ask your AI about Medpace Holdings, Inc.'s accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude